Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Algonquin Power & Utilities
AQN
$4.42B
| $19.9M | ﹤0.01% |
3,160,436
-18,835
| -0.6% | -$142K |
|
1827
AMERISAFE
AMSF
$564M
| $19.9M | ﹤0.01% |
396,667
+13,515
| +4% | +$709K |
|
|
HPP
1828
Hudson Pacific Properties
HPP
$786M
| $19.9M | ﹤0.01% |
426,468
+9,940
| +2% | +$427K |
|
1829
Quanterix
QTRX
$175M
| $19.8M | ﹤0.01% |
730,685
+22,614
| +3% | +$560K |
|
1830
Syndax Pharmaceuticals
SNDX
$1.7B
| $19.8M | ﹤0.01% |
1,360,920
+39,817
| +3% | +$753K |
|
1831
Sphere Entertainment
SPHR
$5.29B
| $19.8M | ﹤0.01% |
531,436
+15,883
| +3% | +$585K |
|
1832
OneSpaWorld
OSW
$2.68B
| $19.7M | ﹤0.01% |
1,758,378
+413,378
| +31% | +$4.82M |
|
1833
Live Oak Bancshares
LOB
$2.03B
| $19.7M | ﹤0.01% |
680,843
+25,584
| +4% | +$823K |
|
1834
Protagonist Therapeutics
PTGX
$8.51B
| $19.7M | ﹤0.01% |
1,181,256
+104,072
| +10% | +$2.02M |
|
1835
Digi International
DGII
$2.65B
| $19.7M | ﹤0.01% |
728,476
+21,419
| +3% | +$736K |
|
1836
Compass
COMP
$8.78B
| $19.6M | ﹤0.01% |
6,769,490
+775,842
| +13% | +$2.74M |
|
|
PACW
1837
DELISTED
PacWest Bancorp
PACW
| $19.6M | ﹤0.01% |
2,477,477
+35,767
| +1% | +$298K |
|
|
INVX
1838
Innovex International
INVX
$1.98B
| $19.6M | ﹤0.01% |
694,295
+24,794
| +4% | +$673K |
|
1839
Pliant Therapeutics
PLRX
$64.4M
| $19.5M | ﹤0.01% |
1,126,214
+137,742
| +14% | +$2.39M |
|
1840
Ecovyst
ECVT
$1.32B
| $19.5M | ﹤0.01% |
1,979,163
+366,776
| +23% | +$3.92M |
|
1841
Phreesia
PHR
$698M
| $19.5M | ﹤0.01% |
1,042,001
+24,274
| +2% | +$653K |
|
1842
Newmark Group
NMRK
$2.72B
| $19.4M | ﹤0.01% |
3,022,766
+62,427
| +2% | +$432K |
|
|
AVID
1843
DELISTED
Avid Technology Inc
AVID
| $19.4M | ﹤0.01% |
722,529
+32,817
| +5% | +$863K |
|
1844
Hain Celestial
HAIN
$45.5M
| $19.4M | ﹤0.01% |
1,868,611
+36,753
| +2% | +$425K |
|
1845
Under Armour
UAA
$2.89B
| $19.4M | ﹤0.01% |
2,826,638
+50,926
| +2% | +$383K |
|
1846
Arcus Biosciences
RCUS
$3.47B
| $19.3M | ﹤0.01% |
1,077,593
+48,671
| +5% | +$978K |
|
1847
Liberty Global Class A
LBTYA
$3.71B
| $19.3M | ﹤0.01% |
1,124,949
-298,449
| -21% | -$5.38M |
|
|
CCF
1848
DELISTED
Chase Corporation
CCF
| $19.2M | ﹤0.01% |
151,200
+4,403
| +3% | +$552K |
|
1849
Kinross Gold
KGC
$27.8B
| $19.2M | ﹤0.01% |
4,244,814
+16,744
| +0.4% | +$82.1K |
|
|
PLYM
1850
DELISTED
Plymouth Industrial REIT
PLYM
| $19.2M | ﹤0.01% |
915,650
+12,604
| +1% | +$284K |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.